Latest Breaking News On - Hope medicine - Page 4 : vimarsana.com

China Digest: Drug developer Hope nets $56m; biotech firm Yikon raises $39m Source: Laurynas Mereckas/Unsplash May 6, 2021 Chinese innovative drug developer Hope Medicine has secured $56 million in a funding round led by investment firms Qiming Venture Partners and Grand Flight Investment, while biotech firm Yikon Genomics has raised 250 million yuan ($38.6 million). Qiming, Grand Flight lead $56m round in drug maker Hope Chinese drug developer Hope Medicine has secured $56 million in a Series B round of financing jointly led by investment firms Qiming Venture Partners and Grand Flight Investment, the startup announced on Thursday. Health-focused investment platform HighLight Capital; Sinovation Ventures, a technology venture capital (VC) firm led by former Google China head Kai-Fu Lee; alongside growth equity firm Trustbridge Partners, which had backed Hope’s Series A round in 2019, all poured capital into the new round.

Ping xiaoKai fu leeLu sijiaBayer agOriza holdingsChina peking universityQide innovation biopharmaceutical equity investment fundTechnology groupTechnology venture capitalHope medicineQiming venture partnersGrand flight investmentYikon genomicsGrand flightHighlight capitalSinovation ventures